{"schema_version":"1","generated_at":"2026-11-20T21:27:48.200Z","data_as_of":null,"url":"https://www.findmykol.com/kol/aasim-sehbai","json_url":"https://www.findmykol.com/kol/aasim-sehbai/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"aasim-sehbai","name":"Aasim Sehbai","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"University of Alabama at Birmingham","institution_url":"https://www.findmykol.com/institution/university-of-alabama-at-birmingham","city":"Anniston","state":"AL","region":{"label":"Southeast","url":"https://www.findmykol.com/region/southeast"}},"identifiers":{"on_file":["npi","openalex"],"values":"Shown on the profile page to a signed-in account."},"summary":"Aasim Sehbai is an Oncology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 34 publications with 206 citations (h-index 8).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":34,"cited_by_count":206,"h_index":8,"latest_activity_year":2025,"emerging":true,"source":"works"},"payments":{"company_count":77,"program_years":{"first":2021,"last":null},"rows_total":189,"shown":3,"withheld":186,"rows":[{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":1700.62,"payment_count":37},{"payer":"Janssen Biotech, Inc.","program_year":2025,"amount_usd":397.15,"payment_count":17},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":334.56,"payment_count":13}],"source":"payments"},"prescribing":{"data_year":2023,"areas_total":12,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":45.4,"classes_total":7,"classes":[{"class":"Other antiemetics","setting":"administered","share_pct":32.2,"drugs":[{"name":"Fosaprepitant","share_pct":100}],"max_beneficiaries":20},{"class":"Serotonin-3 Receptor Antagonist","setting":"mixed","share_pct":12.7,"drugs":[{"name":"Ondansetron hydrochloride","share_pct":71.9},{"name":"Palonosetron hcl","share_pct":22.6},{"name":"Palonosetron Hcl","share_pct":4},{"name":"Ondansetron Hcl","share_pct":0.9},{"name":"Ondansetron Odt","share_pct":0.6}],"max_beneficiaries":39}]},{"area":"Cancer & immunology","share_pct":21,"classes_total":19,"classes":[{"class":"Microtubule Inhibitor","setting":"mixed","share_pct":17.2,"drugs":[{"name":"Paclitaxel","share_pct":99.4},{"name":"Abraxane","share_pct":0.4},{"name":"Docetaxel","share_pct":0.2}],"max_beneficiaries":null},{"class":"Platinum-based Drug","setting":"mixed","share_pct":1.1,"drugs":[{"name":"Carboplatin","share_pct":86.5},{"name":"Oxaliplatin","share_pct":13.5}],"max_beneficiaries":15}]},{"area":"Musculoskeletal","share_pct":18,"classes_total":3,"classes":[{"class":"RANK Ligand Inhibitor","setting":"mixed","share_pct":18,"drugs":[{"name":"Denosumab","share_pct":98.2},{"name":"Xgeva","share_pct":1.1},{"name":"Prolia","share_pct":0.7}],"max_beneficiaries":35},{"class":"Xanthine oxidase inhibitor","setting":"prescribed","share_pct":0,"drugs":[{"name":"Allopurinol","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":99.9,"facility_pct":0.1},"source":"medicare"},"similar":[{"name":"Suzanne Oparil","slug":"suzanne-oparil","institution":"University of Alabama at Birmingham","specialty":"Cardiovascular Disease","url":"https://www.findmykol.com/kol/suzanne-oparil","json_url":"https://www.findmykol.com/kol/suzanne-oparil/profile.json"},{"name":"Richard Whitley","slug":"richard-whitley","institution":"University of Alabama at Birmingham","specialty":"Pediatric Infectious Diseases","url":"https://www.findmykol.com/kol/richard-whitley","json_url":"https://www.findmykol.com/kol/richard-whitley/profile.json"},{"name":"David Standaert","slug":"david-standaert","institution":"University of Alabama at Birmingham","specialty":"Neurology","url":"https://www.findmykol.com/kol/david-standaert","json_url":"https://www.findmykol.com/kol/david-standaert/profile.json"},{"name":"John Hauth","slug":"john-hauth","institution":"University of Alabama at Birmingham","specialty":"Maternal & Fetal Medicine","url":"https://www.findmykol.com/kol/john-hauth","json_url":"https://www.findmykol.com/kol/john-hauth/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":186}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}